Lactational exposure to perfluorooctane sulfonate remains a potential risk in brain function of middle-aged male mice.
Ayane Kate NinomiyaIzuki AmanoHiraku SuzukiYuki FujiwaraAsahi HaijimaNoriyuki KoibuchiPublished in: The journal of physiological sciences : JPS (2024)
Perfluorooctane sulfonate (PFOS) exerts adverse effects on neuronal development in young population. Limited evidences have shown that early-life PFOS exposure holds a potential risk for developing age-related neurodegenerative diseases such as Alzheimer's disease later in life. The present study investigated the effects of lactational PFOS exposure on cognitive function using one-year-old mice. Dams were exposed to PFOS (1 mg/kg body weight) through lactation by gavage. Male offspring were used for the behavior test battery to assess cognitive function. Western blot analysis was conducted to measure the levels of proteins related to the pathogenesis of Alzheimer's disease. PFOS-exposed mice displayed a mild deficiency in social recognition. In the hippocampus, the expression of tau protein was significantly increased. These results underline a mild effect of developing PFOS exposure on cognitive function and neurodegeneration. The present study presents the long-lasting effects of PFOS in middle-aged period and warrants a potential aftermath.
Keyphrases
- middle aged
- body weight
- early life
- healthcare
- cognitive decline
- poor prognosis
- emergency department
- mental health
- white matter
- cerebral ischemia
- high fat diet
- south africa
- binding protein
- brain injury
- preterm infants
- low birth weight
- long non coding rna
- human milk
- atomic force microscopy
- cerebrospinal fluid
- amino acid
- replacement therapy
- high speed
- solid state